PRESTO: A Phase III Randomised Controlled Trial of Dose-escalated Proton Beam Therapy Versus Standard of Care Radiotherapy for Functioning Pituitary Tumours
PRESTO: A Phase III Randomised Controlled Trial of Dose-escalated Proton Beam Therapy Versus Standard of Care Radiotherapy for Functioning Pituitary Tumours
Not yet recruiting · NCT07813351 · Registry updated 2026-10-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PRESTO: A Phase III Randomised Controlled Trial of Dose-escalated Proton Beam Therapy Versus Standard of Care Radiotherapy for Functioning Pituitary Tumours | ACTH-dependent Cushing syndrome, Bone Diseases, Endocrine, Growth Hormone-Secreting Pituitary Adenoma, Neoplasms by Histologic Type, Neoplasms by Site, Pituitary Neoplasms, acromegaly, adenoma, bone disorder, brain disorder, central nervous system cancer, central nervous system disorder, endocrine system disorder, epithelial neoplasm, hyperpituitarism, hypothalamic disorder, hypothalamic neoplasm, malignant endocrine neoplasm, musculoskeletal system disorder, neoplasm, nervous system disorder, pituitary gland adenoma, pituitary gland disorder, supratentorial cancer | Not yet recruiting | Phase 3 | 2026-10-01 | NCT07813351 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute for Health and Care Research | 2 |
| University College, London | 222 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||